![]() |
市場調查報告書
商品編碼
1351020
2023-2030 年全球胎兒電子心電圖 (FECG) 監視器市場Global Fetal Electronic Cardiodiagram (FECG) Monitors Market 2023-2030 |
預計全球 FECG 監視器市場在預測期內將以 7.0% 的年複合成長率顯著成長。支持市場擴張的主要因素包括人們對胎兒監測及其益處的認知不斷提高,以及全球醫療保健基礎設施的過度支出。電子胎兒監視器持續監測嬰兒的心跳,通常在分娩過程中使用,以確保嬰兒在分娩過程中不會缺氧,因為缺氧會導致腦損傷。因此,在醫療保健可近性不斷改善的新興經濟體中,對先進監測設備的需求大幅增加。例如,2021 年 2 月進行了一項研究,旨在調查在印度比哈爾邦地區醫院實施 Moyo 胎兒心率監測儀 (FHRM) 的可行性。該研究旨在確定實施 Moyo FHRM 的障礙和促進因素,並評估產科和新生兒結果數據的可靠性。
全球胎兒電子心電圖 (FECG) 監視器市場根據其類型、應用、技術和最終用戶細分進行分類。根據其類型,市場分為攜帶式和固定式。在考慮應用時,細分市場包括醫院、診所和家庭使用。此外,市場根據技術進一步分類,包括直接接觸式和非接觸式兩類。根據最終用戶,市場分為醫院藥房、零售藥房和網路藥房。在該類型細分市場中,攜帶式子細分市場由於其遠端操作的非凡便利性預計將佔據相當大的市場佔有率。
在攜帶式細分市場中,固定式細分市場預計在預測期內將顯著成長。這種成長歸因於多種因素,包括由於其便利性而在醫院環境中擴大採用此類監視器。在先進的醫療設施中,固定式胎兒監視器是持續監測胎兒健康的重要工具。因此,推動幾家主要醫療機構整合升級且配備精良的技術監視器。例如,2022 年,GE 醫療保健開始提供 Novii Wireless 固定式 FECG 監視器。 Novii 無線貼片系統是一款 FECG 監測設備,用於監測懷孕期間的胎心率。它們提供了一種分析胎心率的非侵入性方法,顯示胎兒的生長和健康狀況。新推出的系統是一種母嬰監視器,可以非侵入性地測量和顯示胎兒心率、母體心率和子宮活動。
全球胎兒電子心電圖(FECG)監視器市場根據地理區域進一步細分,包括北美(美國和加拿大)、歐洲(義大利、西班牙、德國、法國等)、亞太地區(印度、中國、日本、韓國等)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於完善的醫療基礎設施以及先進醫療技術的日益採用,預計歐洲市場在預測期內將大幅成長。同時,在不斷改善的醫療設施和不斷成長的醫療支出的推動下,亞太地區的全球胎兒電子心電圖(FECG)監視器市場預計將大幅成長。
北美地區預計將在全球胎兒電子心電圖(FECG)監視器市場中佔據重要佔有率。區域胎兒心電監視器市場的成長主要是由於胎兒監護在醫療保健實踐中相對較高的普及率以及先進醫療設施的存在。
全球 FECG 監視器市場的主要公司包括: FUJIFILM Corp.、GE HealthCare Technologies Inc.、Mindray、Koninklijke Philips NV、Siemens Healthineers 等。這些市場參與者透過各種策略積極促進市場成長,包括併購、合作、合作、融資和新產品發布,以保持其在市場上的競爭力。例如,2021 年 7 月,德州婦女兒童館與 PeriGen 合作進行了一個項目,在非洲馬拉威的一家醫院內實施 PeriWatch Vigilance 自動預警系統。這項創新系統旨在持續監測母嬰訊息,旨在避免潛在的併發症並減少與分娩相關的死亡人數。
Title: Global Fetal Electronic Cardiodiagram (FECG) Monitors Market Size, Share & Trends Analysis Report by Type (Portable and Stationary), by Application (Hospitals, Clinics, and Home Use), by Technology (Direct Contact and Non-contact), and by End-User (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies),Forecast Period (2023-2030).
The global FECG monitors market is projected to grow at a significant CAGR of 7.0% during the forecast period. The primary factor supporting the market expansion includes the rising awareness about fetal monitoring and its benefits along with excessive spending in healthcare infrastructure around the globe. Electronic fetal monitoring continuously monitors a baby's heartbeat, often used during labor to ensure that babies do not lack of oxygen during labor, as it results in brain damage. Consequently, there is a considerable increase in demand for advanced monitoring devices several in emerging economies where healthcare access is improving. For instance, in February 2021, a study was conducted in order to investigate the feasibility of implementing the Moyo fetal heart rate monitor (FHRM) in district hospitals of Bihar state, India. The study aimed to identify the barriers and facilitators for the implementation of Moyo FHRM and assess the reliability of obstetrical and neonatal outcome data.
The global fetal electronic cardiodiagram (FECG) monitors market is categorized based on its type, application, technology, and end-user segments. Based on its type, the market is divided into portable and stationary. When considering the application, the market segments include hospitals, clinics, and home use. Moreover, the market is further divided based on technology which includes direct contact and non-contact categories. Based on the end-user, the market is sub-segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Among the type segment, portable sub-segment is anticipated to capture a substantial market share, owing to its extraordinary convenience of remote operating.
Among the portable sub-segment, the stationary sub-segment is expected to experience significant growth during the forecast period. This growth is attributed to factors including the increased adoption of such monitors in hospital settings owing to its convenience offered. In advanced medical facilities, stationary fetal monitors are essential tools for continuous monitoring of fetal health. Thus, pushed several major healthcare organizations to integrate upgraded and well-equipped technological monitors. For instance, in 2022. GE Healthcare started providing Novii Wireless stationary FECG monitors. The Novii Wireless Patch System is a FECG monitoring device used for monitoring the FHR during pregnancy. They provide a non-invasive method of analyzing the fetal heart rate, indicating the growth and well-being of the fetus. The newly introduced system is a maternal/fetal monitor that non-invasively measures and displays fetal heart rate, maternal heart rate, and uterine activity.
The global fetal electronic cardiodiagram (FECG) monitors market is further segmented based on geographical regions, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Europe market is expected to experience substantial growth over the forecast period owing to well-established healthcare infrastructure coupled with the increasing adoption of advanced medical technologies. Meanwhile, the Asia-Pacific region is projected to witness considerable growth in the global fetal electronic cardiodiagram (FECG) monitors market, driven by continuously improving healthcare facilities and rising healthcare spending.
The North American region is expected to hold a significant share in the global fetal electronic cardiodiagram (FECG) monitors market. The regional FECG monitor market growth is primarily bolstering due to a comparatively high prevalence of fetal monitoring in healthcare practices and the presence of advanced medical facilities.
Major companies operating in the global FECG Monitors market include: FUJIFILM Corp., GE HealthCare Technologies Inc., Mindray, Koninklijke Philips N.V., Siemens Healthineers, and others. These market players are actively contributing to market growth through various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, in order to maintain their competitiveness in the market. For instance, in July 2021, in partnership with PeriGen, the Texas Children's Pavilion for Women has undertaken a project to implement the PeriWatch Vigilance automated early warning system within a hospital located in Malawi, Africa. This innovative system is designed to consistently monitor maternal and fetal information, aiming to avert potential complications and reduce childbirth-related fatalities.